Evidence map›Paper›PMID 24391740›Full record

ArticlePloS one2013

Urotensin-II system in genetic control of blood pressure and renal function.

Radoslaw Debiec, Paraskevi Christofidou, Matthew Denniff, Lisa D Bloomer, Pawel Bogdanski, Lukasz Wojnar, Katarzyna Musialik, Fadi J Charchar, John R Thompson, Dawn Waterworth and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Urotensin II system in chronic kidney disease.Current research in physiology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 5 countries.

Radoslaw DebiecDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Paraskevi ChristofidouDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Matthew DenniffDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Lisa D BloomerDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Pawel BogdanskiDepartment of Internal Medicine, Metabolic Disorders and Hypertension, Medical University of Poznan, Poznan, Poland.
Lukasz WojnarDepartment of Urology and Oncological Urology, Medical University of Poznan, Poznan, Poland.
Katarzyna MusialikDepartment of Internal Medicine, Metabolic Disorders and Hypertension, Medical University of Poznan, Poznan, Poland.
Fadi J CharcharSchool of Science and Engineering, University of Ballarat, Ballarat, Australia.
John R ThompsonDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Dawn WaterworthGlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
Kijoung SongGlaxoSmithKline, Philadelphia, Pennsylvania, United States of America.
Peter VollenweiderDepartment of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Gerard WaeberDepartment of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Ewa Zukowska-SzczechowskaDepartment of Internal Medicine, Diabetology and Nephrology, Medical University of Silesia, Zabrze, Poland.
Nilesh J SamaniDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
David LambertDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Maciej TomaszewskiDepartment of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
University of Leicester · GBPoznan University of Medical Sciences · PLGlaxoSmithKline (United States) · USUniversity Hospital of Lausanne · CHFederation University · AUMedical University of Silesia · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urotensin-II controls ion/water homeostasis in fish and vascular tone in rodents. We hypothesised that common genetic variants in urotensin-II pathway genes are associated with human blood pressure or renal function. We performed family-based analysis of association between blood pressure, glomerular filtration and genes of the urotensin-II pathway (urotensin-II, urotensin-II related peptide, urotensin-II receptor) saturated with 28 tagging single nucleotide polymorphisms in 2024 individuals from 520 families; followed by an independent replication in 420 families and 7545 unrelated subjects. The expression studies of the urotensin-II pathway were carried out in 97 human kidneys. Phylogenetic evolutionary analysis was conducted in 17 vertebrate species. One single nucleotide polymorphism (rs531485 in urotensin-II gene) was associated with adjusted estimated glomerular filtration rate in the discovery cohort (p = 0.0005). It showed no association with estimated glomerular filtration rate in the combined replication resource of 8724 subjects from 6 populations. Expression of urotensin-II and its receptor showed strong linear correlation (r = 0.86, p<0.0001). There was no difference in renal expression of urotensin-II system between hypertensive and normotensive subjects. Evolutionary analysis revealed accumulation of mutations in urotensin-II since the divergence of primates and weaker conservation of urotensin-II receptor in primates than in lower vertebrates. Our data suggest that urotensin-II system genes are unlikely to play a major role in genetic control of human blood pressure or renal function. The signatures of evolutionary forces acting on urotensin-II system indicate that it may have evolved towards loss of function since the divergence of primates.

Indexed as

AdolescentAdultAgedAnimalsBlood PressureCohort StudiesEvolution, MolecularFemaleGene ExpressionGenetic Association StudiesGlomerular Filtration RateHumansHypertensionIntracellular Signaling Peptides and ProteinsKidneyMaleIntracellular Signaling Peptides and ProteinsPeptide HormonesReceptors, G-Protein-Coupledurotensin IIUrotensinsUTS2B protein, humanUTS2R protein, human

Identifiers

PMID24391740
PMCPMC3877024
OpenAlexW2071330699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.